Company profile

SENSEERA

Empowering diagnostics and drug development with AI-driven chromatin liquid biopsy

Industry
Biotechnology Research
Employees
19
Headquarters
Jerusalem
Founded
2020
Office locations
1

SENSEERA company summary

SENSEERA is a company in the Biotechnology Research industry, headquartered in Jerusalem, founded in 2020. On LinkedIn the company has around 19 employees.

What technology does SENSEERA use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About SENSEERA

Senseera’s novel chromatin-based liquid biopsy (Sadeh et al., Nature Biotechnology, 2021) is a patented, first-in-class biomarker discovery platform. GEM (Genomic Expression Maps) Biomarkers convert a simple blood draw into high-resolution, quantitative, cell-specific gene expression and regulatory data from cell-free DNA—reflecting the activity of tissues and organs across the body. Surpassing traditional cfDNA genomics and methylation techniques, GEM Biomarkers provide a transformative data layer enabling applications such as biomarker discovery, tissue-agnostic MRD detection, therapy response monitoring, dose optimization, disease subtyping, and more. With a growing database of over 20,000 annotated disease samples and a cohort of more than 2,000 healthy individuals, Senseera partners with leading pharmaceutical and biotech companies to deliver mechanistic insights with unmatched sensitivity and specificity—accelerating drug development and advancing precision medicine worldwide.

Where is SENSEERA located?

SENSEERA lists 1 location.

Jerusalem, IL, ILHQ
Professor Racah street

Compare companies similar to SENSEERA

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
SENSEERA
senseerahealth.com
Biotechnology Research192020Jerusalem
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about SENSEERA

What does SENSEERA do?

Senseera’s novel chromatin-based liquid biopsy (Sadeh et al., Nature Biotechnology, 2021) is a patented, first-in-class biomarker discovery platform. GEM (Genomic Expression Maps) Biomarkers convert a simple blood draw into high-resolution, quantitative, cell-specific gene expression and regulatory data from cell-free DNA—reflecting the activity of tissues and organs across the body. Surpassing traditional cfDNA genomics and methylation techniques, GEM Biomarkers provide a transformative data layer enabling applications such as biomarker discovery, tissue-agnostic MRD detection, therapy response monitoring, dose optimization, disease subtyping, and more. With a growing database of over 20,000 annotated disease samples and a cohort of more than 2,000 healthy individuals, Senseera partners with leading pharmaceutical and biotech companies to deliver mechanistic insights with unmatched sensitivity and specificity—accelerating drug development and advancing precision medicine worldwide.

How many employees does SENSEERA have?

SENSEERA has around 19 employees on LinkedIn.

Where is SENSEERA headquartered?

SENSEERA is headquartered in Jerusalem.

When was SENSEERA founded?

SENSEERA was founded in 2020.

Build a lead list from companies like SENSEERA

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.